Pharmaceutical Industry in
Riehen

Alpha-O Peptides AG

Since 2003 · 1–10 empl.

Alpha-O Peptides AG develops technologies in therapeutics and biotechnology and licenses them to qualified industry partners. The company focuses on peptide- and protein-based self-assembling nanoparticle platforms for vaccine, antigen-display and drug-delivery applications, as reflected in its patent portfolio.

Ymmunobio AG

Since 2021 · 21–50 empl.

The core activity of Ymmunobio is the development of preclinical cancer therapeutics, particularly antibodies that influence the immune system and directly inhibit cancer cells. The company focuses on developing innovative treatments for cancer patients, especially for solid tumors, and has already made progress in developing antibodies that reactivate the immune system and directly inhibit cancer cells.

metaShape Pharma AG

Since 2023 · 1–10 empl.

The core activity of MetaShape Pharma AG is the development and marketing of pharmaceutical products and services in the life sciences sector. The company is active in the research and development of medicines and therapies, and also offers services such as market research, asset evaluation and communication management.

Zysthera GmbH

Since 2022 · 1–10 empl.

Stamm and Friends GmbH

Since 2005 · 11–20 empl.

The company is active in the pharmaceutical industry, specifically in the field of generics. The core activity includes searching for new developments, technologies and documentation for medicinal products, identifying and qualifying manufacturers, negotiating contracts and marketing generics and other pharmaceutical products. The company has an international network and has offices in Switzerland and China.

FRIEDRICH WOLFF AG

Since 1996 · 1–10 empl.

cureab gmbh

Since 2012 · 1–10 empl.

CIMAVIS AG

Since 2020 · 1–10 empl.

Joost Louwagie Consulting

Since 2024 · 1–10 empl.